Arctic Bioscience AS: CFO to Resign at End of 2026

Jone Slinning has decided to resign from his position as Chief Financial Officer at Arctic Bioscience AS, with his tenure concluding at the end of 2026. The decision stems from Slinning's desire to pursue opportunities outside the company. He has committed to remaining in his role until December 31, 2026, to facilitate a smooth handover of responsibilities.

The Board of Directors expressed gratitude for Slinning's contributions during his time with the company and wished him success in his future endeavors. Arctic Bioscience AS has initiated a process to appoint a successor for the CFO position and will provide further updates in due course.

Slinning's role has been integral to the company's financial management. His extended stay until the end of 2026 allows Arctic Bioscience time to find and onboard a new executive, ensuring continuity in financial operations during this transition period.